GH Guardant Health Inc

USD 17.45 -0.29 -1.634724
Icon

Guardant Health Inc (GH) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 17.45

-0.29 (-1.63)%

USD 2.16B

2.15M

USD 38.57(+121.04%)

USD 53.33 (+205.62%)

Icon

GH

Guardant Health Inc (USD)
COMMON STOCK | NSD
USD 17.45
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.16B

USD 53.33 (+205.62%)

USD 17.45

Guardant Health Inc (GH) Stock Forecast

Show ratings and price targets of :
USD 38.57
(+121.04%)

Based on the Guardant Health Inc stock forecast from 7 analysts, the average analyst target price for Guardant Health Inc is USD 38.57 over the next 12 months. Guardant Health Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Guardant Health Inc is Bearish, which is based on 2 positive signals and 8 negative signals. At the last closing, Guardant Health Inc’s stock price was USD 17.45. Guardant Health Inc’s stock price has changed by -8.11% over the past week, -22.17% over the past month and -37.54% over the last year.

No recent analyst target price found for Guardant Health Inc
No recent average analyst rating found for Guardant Health Inc

Company Overview Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test...Read More

https://guardanthealth.com

3100 Hanover Street, Palo Alto, CA, United States, 94304

1,768

December

USD

USA

Adjusted Closing Price for Guardant Health Inc (GH)

Loading...

Unadjusted Closing Price for Guardant Health Inc (GH)

Loading...

Share Trading Volume for Guardant Health Inc Shares

Loading...

Compare Performance of Guardant Health Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GH

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Guardant Health Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc +0.04 (+0.01%) USD40.08B 49.24 34.23

ETFs Containing GH

Symbol Name GH's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Guardant Health Inc (GH) Stock

Based on ratings from 7 analysts Guardant Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 8 buy, sell and hold ratings.

Unfortunately we do not have enough data on GH's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for GH is USD 38.57 over the next 12 months. The maximum analyst target price is USD 50 while the minimum anlayst target price is USD 27.

GH stock's Price/Earning ratio is 10.05. Our analysis grades GH stock's Price / Earning ratio at C-. This means that GH stock's Price/Earning ratio is above 30% of the stocks in the Diagnostics & Research sector in the NSD exchange. Based on this GH may be undervalued for its sector.

The last closing price of GH's stock was USD 17.45.

The most recent market capitalization for GH is USD 2.16B.

Based on targets from 7 analysts, the average taret price for GH is projected at USD 38.57 over the next 12 months. This means that GH's stock price may go up by +121.04% over the next 12 months.

We can't find any ETFs which contains Guardant Health Inc's stock.

As per our most recent records Guardant Health Inc has 1,768 Employees.

Guardant Health Inc's registered address is 3100 Hanover Street, Palo Alto, CA, United States, 94304. You can get more information about it from Guardant Health Inc's website at https://guardanthealth.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...